Tobramycin Injection Franchise in Ahmedabad

Antibiotic Injection Supplier in Mumbai

Critical Care Injection Distributor in Delhi

Hospital PCD Pharma Franchise in Bangalore

Tobramycin Injection Stockist in Hyderabad
Antibiotic Injection Manufacturer & Exporter in Chandigarh

Home/Products /tobramycin-20mg-injection

Tobraxyle 20 Injection

Composition : Tobramycin (20mg) Injection

Dosage Form : Injection

Packaging Type : Vial

Packaging : 2ml

Price : ₹1/-

Tobraxyle 20 Injection contains Tobramycin 20mg, a potent aminoglycoside antibiotic used for the treatment of serious bacterial infections, especially those caused by gram-negative organisms. It is widely used in hospital and critical care settings.

Tobramycin works by inhibiting bacterial protein synthesis, leading to rapid bacterial cell death. Its strong bactericidal activity makes it effective against severe infections where prompt antimicrobial action is required.

This injection is commonly prescribed for respiratory tract infections, urinary tract infections, septicemia, skin and soft tissue infections, and intra-abdominal infections, particularly in hospitalized patients under medical supervision.

For PCD pharma franchise partners, Tobraxyle 20 Injection is a high-value antibiotic product, available at the best price for PCD pharma franchise. Its consistent hospital demand, inclusion in critical care protocols, and strong clinician trust make it an essential addition to any injectable or antibiotic-focused portfolio.

Read More

About the Product

Tobraxyle 20 Injection contains Tobramycin 20mg, a potent aminoglycoside antibiotic used for the treatment of serious bacterial infections, especially those caused by gram-negative organisms. It is widely used in hospital and critical care settings.

Tobramycin works by inhibiting bacterial protein synthesis, leading to rapid bacterial cell death. Its strong bactericidal activity makes it effective against severe infections where prompt antimicrobial action is required.

This injection is commonly prescribed for respiratory tract infections, urinary tract infections, septicemia, skin and soft tissue infections, and intra-abdominal infections, particularly in hospitalized patients under medical supervision.

For PCD pharma franchise partners, Tobraxyle 20 Injection is a high-value antibiotic product, available at the best price for PCD pharma franchise. Its consistent hospital demand, inclusion in critical care protocols, and strong clinician trust make it an essential addition to any injectable or antibiotic-focused portfolio.

Common side effects may include injection site reactions, nausea, headache, or fever. Prolonged or high-dose use may cause nephrotoxicity (kidney impairment) or ototoxicity (hearing or balance disturbances). Regular monitoring of renal function and auditory status is advised during therapy.

Tobraxyle 20 Injection is indicated for the treatment of severe bacterial infections such as respiratory tract infections, urinary tract infections, septicemia, skin and soft tissue infections, intra-abdominal infections, and bone or joint infections caused by susceptible organisms. It is commonly used in hospitalized patients under medical supervision.

Tobraxyle 20 Injection should be administered only by healthcare professionals. Dosage and duration must be strictly followed as prescribed by the physician. Caution is required in patients with kidney disorders, hearing problems, or dehydration. Do not use without proper medical supervision.

Store Tobraxyle 20 Injection in a cool, dry place away from direct light. Keep the vial properly sealed and out of reach of children. Do not use if the solution shows discoloration or particulate matter.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation